The animal models services global market is expected to grow at single digit CAGR to reach $962.2 million by 2025
The animal model Services global market was estimated region wise, type of animal species and therapeutic area. This report also contains ethics and regulations, animal model alternatives and applications. Assessment of most common animal models across different therapeutic areas was included. Key developments such as collaborations, acquisitions, new launches, partnerships and expansions were reported and analyzed.
Classical pharmacological models or animal models are used as a mandatory element in preclinical (toxicological and pharmacological) studies of new drugs. Although in recent years, the replacement of animal testing and animal models with in-vitro models has been increasingly introduced into practice, according to the modern manuals of pharmaco-toxicological preclinical study, some animal studies still remain compulsory.
Key Topics Covered:
1 Animal Model Services Global Market 1.1 Executive Summary
2 Market Analysis 2.1 Factors Influencing Market 2.1.1 Drivers and Opportunities 2.1.1.1 Need for Preclinical Studies for the Approval of Therapeutics 2.1.1.2 Complexity of Biologics Makes Animal Testing Very Important for Safety Data 2.1.1.3 Increased Investment in R&D by Pharmaceutical Companies is Increasing the Outsourcing 2.1.1.4 Genetic Engineering Advancements in the Resent Years Will Increase the Use of Animal Models 2.1.1.5 Requirement of Novel Biologics Therapeutics for Certain Diseases 2.1.2 Restraints and Threats 2.1.2.1 High Cost of Animal Studies 2.1.2.2 Requirement of Large Number of Animals for Most Studies 2.1.2.3 Ethical Concerns and Stringent Regulations 2.1.2.4 Threat from Alternatives
3 Animal Model Services 3.1 Introduction 3.1.1 Comparison Matrix of Animal Models and Applications 3.1.2 Small Animal Models 3.1.3 Large Animal Models 3.2 Ethics and Regulations 3.3 Alternatives to Animal Models 3.4 Overview of Applications of Animal Models 3.5 Market Share Analysis 3.6 Competitive Landscape 3.7 Company Developments
The federal Liberal-NDP coalition government recently announced it would work with the provinces to fund universal prescription drug benefits for contraceptives and diabetes medications. It is the first step toward a national pharmacare program that...
The "GSK3528869A Bepirovirsen Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive insights about GSK3528869A Bepirovirsen for chronic hepatitis B in the...
As part of its ongoing commitment to building industry-leading fitness and wellness curriculum and enhancing student experiences while also prioritizing environmental sustainability, the International Sports Sciences Association (ISSA) has announced...
The Rock Creek Foundation, a staple of support for individuals with intellectual disabilities and mental illness in Montgomery County, MD and the Greater Washington region, will host its 50th Anniversary Gala on Thursday, April 18th, from 6pm to...
HealthSignals is proud to announce the attainment of a national group purchasing agreement for Telehealth with Premier, Inc. Effective 03/01/2024, this agreement empowers Premier members to benefit from specially negotiated pricing and terms for...
Evofem Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) issued to the Company a Notice of Allowance for patent application 17/823,020 entitled, "Compositions and Methods for Enhancing...